Wnt1 oversees microglial activation by the Wnt/LRP5/6 receptor signaling pathway during lipopolysaccharide-mediated

Wang Qing1, Xu Hao1, Sun Xuan1

  • 1Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, China.

PubMed
Abstract

Insights

Wnt1 reduces neuroinflammation in microglia by enhancing autophagy, a process partly mediated by the Wnt/β-catenin pathway and LKB1 phosphorylation. This reveals a novel anti-inflammatory mechanism for Wnt1 in central nervous system diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglial inflammatory regulation via autophagy shows promise for central nervous system (CNS) diseases.
  • Wnt/β-catenin signaling is protective in neurodegenerative diseases, but its link to microglial activation is unclear.
  • This study investigates the mechanism of Wnt1's impact on microglial activation.

Purpose of the Study:

  • To elucidate the mechanism by which Wnt1 influences microglial activation.
  • To explore the relationship between Wnt1/β-catenin signaling and microglial inflammatory responses.
  • To understand the role of autophagy in Wnt1-mediated anti-inflammatory effects.

Main Methods:

  • BV2 cells were stimulated with lipopolysaccharide to mimic neuroinflammation.
  • Flow cytometry and immunofluorescence identified cell markers (CD86, CD206).
  • ELISA measured inflammatory factors; autophagy was assessed via LC3B puncta and protein expression (LC3, P62, beclin1).

Main Results:

  • rhWnt1 suppressed inflammatory activation, an effect blocked by DKK1, siRNA-β-catenin, and siRNA-LKB1.
  • Wnt1 enhanced autophagy, which was partially inhibited by siRNA-LKB1 and 3-MA.
  • The Wnt1/LKB1 pathway's anti-inflammatory effect was independent of β-catenin but regulated its expression.

Conclusions:

  • Wnt1 exerts anti-inflammatory effects on microglia by enhancing autophagy.
  • This mechanism involves the Wnt/β-catenin pathway and LKB1 phosphorylation.
  • Wnt1 presents a novel therapeutic target for CNS diseases due to its anti-inflammatory properties.